SCHEMBL7775633

SCHEMBL7775633

COc1ccccc1N1CCN(CC(CC(=O)N2CCCCCC2)c2ccccn2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.57
ALDH1A1 P00352 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
HTR1A P08908 9/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
DRD2 P14416 3/20 0.52
HTR2B P41595 2/20 0.52
HTR1D P28221 1/20 0.52
TSHR P16473 2/20 0.50
ADRA1A P35348 4/20 0.49
DRD4 P21917 4/20 0.48
ADRA1D P25100 3/20 0.48
ADRA1B P35368 3/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
HTR1B P28222 1/20 0.48
HTR7 P34969 1/20 0.48
HTR2A P28223 2/20 0.47
DRD3 P35462 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6546626 0.85 ALDH1A1 (0.65) KDM4EALDH1A1TDP1HTR1ADRD2
SCHEMBL6064337 0.85 HTR1A (0.62) HTR1AMEN1KMT2ADRD2HTR2B
SCHEMBL10753828 0.78 IGF1R (0.63) KDM4EALDH1A1TDP1HTR1AMEN1
SCHEMBL6547111 0.76 MAPT (0.53) KDM4EALDH1A1TDP1HTR1AMEN1
SCHEMBL8781395 0.75 HTR1A (0.73) KDM4EALDH1A1HTR1AMEN1KMT2A
SCHEMBL8442654 0.74 HTR1A (0.80) KDM4EALDH1A1TDP1HTR1ADRD2
SCHEMBL9004457 0.74 HTR1A (0.80) KDM4EALDH1A1TDP1HTR1ADRD2
SCHEMBL10756919 0.74 DRD2 (0.52) KDM4EALDH1A1TDP1HTR1AMEN1
SCHEMBL8648451 0.74 HTR1A (0.55) HTR1AMEN1KMT2ADRD2HTR2B
Cyclohexane SCHEMBL8646429 0.74 HTR1A (0.54) ALDH1A1HTR1AMEN1KMT2ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1123926-A1 Piperazine derivatives for treatment of CNS disorders JOHN WYETH & BROTHER LIMITED (GB) 2001-08-16 EP claimed
US-5369103-A Anxiolytic agents, cental nervous system disorders JOHN WYETH & BROTHER, LIMITED (GB) 1994-11-29 US claimed
EP-0506905-A1 PIPERAZINE DERIVATIVES JOHN WYETH & BROTHER LIMITED (GB) 1992-10-07 EP claimed
WO-1992006960-A1 PIPERAZINE DERIVATIVES JOHN WYETH & BROTHER LIMITED (GB) 1992-04-30 WO claimed
EP-1123926-A1 Piperazine derivatives for treatment of CNS disorders JOHN WYETH & BROTHER LIMITED (GB) 2001-08-16 EP disclosed
US-5369103-A Anxiolytic agents, cental nervous system disorders JOHN WYETH & BROTHER, LIMITED (GB) 1994-11-29 US disclosed